United Capital Financial Advisors’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-21,029
Closed -$228K 1206
2025
Q2
$228K Sell
21,029
-63
-0.3% -$825 ﹤0.01% 1013
2025
Q1
$390K Sell
21,092
-90
-0.4% -$1.62K ﹤0.01% 814
2024
Q4
$349K Sell
21,182
-43
-0.2% -$609 ﹤0.01% 839
2024
Q3
$298K Sell
21,225
-26
-0.1% -$288 ﹤0.01% 878
2024
Q2
$154K Sell
21,251
-752
-3% -$5.14K ﹤0.01% 991
2024
Q1
$178K Sell
22,003
-133
-0.6% -$1.19K ﹤0.01% 1033
2023
Q4
$151K Buy
+22,136
New +$123K ﹤0.01% 1018

Other funds holding AXGN

United Capital Financial Advisors's AXGN Position: Q3 2025 in Review

United Capital Financial Advisors sold out of Axogen (AXGN) in Q3 2025, closing a stake of 21,029 shares — an estimated $228K sold.

United Capital Financial Advisors first reported a position in AXGN in Q4 2023 and held it in 7 quarters. The position peaked at $390K in Q1 2025. 171 funds tracked by Wall St. Rank hold AXGN as of Q3 2025.

  • United Capital Financial Advisors reported no remaining Axogen position as of Q3 2025 after selling out during the quarter.
  • United Capital Financial Advisors sold 21,029 Axogen shares in Q3 2025, an estimated $228K.
  • United Capital Financial Advisors first reported a position in Axogen in Q4 2023 and held it in 7 quarters.
  • United Capital Financial Advisors's Axogen position peaked at $390K in Q1 2025.
  • 171 funds tracked by Wall St. Rank held Axogen as of Q3 2025.

Based on United Capital Financial Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.